BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16515784)

  • 1. ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance.
    Oh SY; Song JH; Gil JE; Kim JH; Yeom YI; Moon EY
    Exp Cell Res; 2006 May; 312(9):1651-7. PubMed ID: 16515784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1alpha stabilization in HeLa human cervical tumor cells.
    Oh JM; Moon EY
    Life Sci; 2010 Aug; 87(9-10):286-93. PubMed ID: 20637781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death.
    Moon EY; Song JH; Yang KH
    Oncol Res; 2007; 16(11):507-16. PubMed ID: 18306930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells.
    Oh JM; Ryoo IJ; Yang Y; Kim HS; Yang KH; Moon EY
    Cancer Lett; 2008 Jun; 264(1):29-35. PubMed ID: 18272284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells.
    Tan H; Ling H; He J; Yi L; Zhou J; Lin M; Su Q
    Arch Pharm Res; 2008 Jun; 31(6):786-93. PubMed ID: 18563362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
    Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance.
    Kiely B; Feldman G; Ryan MP
    Kidney Int; 2003 Mar; 63(3):908-16. PubMed ID: 12631071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.
    Suyama H; Igishi T; Sano H; Matsumoto S; Shigeoka Y; Nakanishi H; Endo M; Burioka N; Hitsuda Y; Shimizu E
    Int J Oncol; 2004 Jun; 24(6):1499-504. PubMed ID: 15138593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
    Stadheim TA; Xiao H; Eastman A
    Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.
    Asada S; Daitoku H; Matsuzaki H; Saito T; Sudo T; Mukai H; Iwashita S; Kako K; Kishi T; Kasuya Y; Fukamizu A
    Cell Signal; 2007 Mar; 19(3):519-27. PubMed ID: 17113751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes.
    Lee SK; Jang HJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
    Life Sci; 2006 Sep; 79(15):1419-27. PubMed ID: 16697418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway.
    Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF
    Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Di-(2-ethylhexyl) phthalate-induced tumor growth is regulated by primary cilium formation via the axis of H
    Lee JW; Thuy PX; Han HK; Moon EY
    Int J Med Sci; 2021; 18(5):1247-1258. PubMed ID: 33526986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic stretch induces proliferation and TGF-beta1-mediated apoptosis via p38 and ERK in ureteric bud cells.
    Fujita H; Hida M; Kanemoto K; Fukuda K; Nagata M; Awazu M
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F648-55. PubMed ID: 20392803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
    Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A
    Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.